# Cadrus Therapeutics, Inc. — Form D

Cadrus Therapeutics, Inc. of WORCESTER, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-20. The offering totals $500K, of which $40K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-05-20
- Form: D
- Accession: 0001464357-09-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $500K
- Amount sold: $40K
- Remaining: $460K
- Investors: 4
- Date of first sale: 2009-05-08
- Revenue range: Decline to Disclose
- SEC file number: 021-131373

## Issuer

- Name: Cadrus Therapeutics, Inc.
- CIK: 0001464357
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2009
- Address: 67 MILLBROOK STREET, WORCESTER, MA, 01616
- Phone: (508) 842-7133

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| David Easson | Director | Worcester, MA |
| David Easson | Executive Officer | Worcester, MA |

## More

- [CIK 1464357 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1464357&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001464357-09-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.